Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Fosrenol Approved In Higher Dose Formulation

Nov 28 2005

• By Kathryn Phelps

Related Content

Shire's Fosrenol Gets FDA Nod, Will Be Available By Year-End

Oct 27 2004

Shire's Fosrenol Is Boosting ESRD Market, Not Switching Renagel Patients, Genzyme Says

Apr 21 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window